Bertrand Clerc
YOU?
Author Swipe
View article: Data from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Data from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
Purpose: To evaluate CD4+ helper functions and antitumor effect of promiscuous universal cancer peptides (UCP) derived from telomerase reverse transcriptase (TERT).Experimental Design: To evaluate the widespread im…
View article: Supplementary Figure 4 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 4 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 57K, UCPs mediated helper effect on CTLs in other models of vaccinations
View article: Supplementary Figure 3 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 3 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 38K, Comparison of T-cell help mediated by UCP2 and a HTLV-1 Tax-derived peptide on self/TERT pY988 specific CTL response
View article: Supplementary Figure 1 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 1 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 51K, Isolation of UCP4-specific CD4 Th1 cell clone from a cancer patient
View article: Supplementary Methods and Figure Legend from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Methods and Figure Legend from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 106K
View article: Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 26K, UCP2 specific CD4 T cells recognize the mTERT-derived counterpart peptide p568
View article: Supplementary Figure 2 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 2 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 65K, UCP2 and UCP4 peptides increase self/TERT pY572 specific CTL responses
View article: Data from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Data from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
Purpose: To evaluate CD4+ helper functions and antitumor effect of promiscuous universal cancer peptides (UCP) derived from telomerase reverse transcriptase (TERT).Experimental Design: To evaluate the widespread im…
View article: Supplementary Figure 3 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 3 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 38K, Comparison of T-cell help mediated by UCP2 and a HTLV-1 Tax-derived peptide on self/TERT pY988 specific CTL response
View article: Supplementary Figure 2 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 2 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 65K, UCP2 and UCP4 peptides increase self/TERT pY572 specific CTL responses
View article: Supplementary Methods and Figure Legend from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Methods and Figure Legend from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 106K
View article: Supplementary Figure 1 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 1 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 51K, Isolation of UCP4-specific CD4 Th1 cell clone from a cancer patient
View article: Supplementary Figure 4 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 4 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 57K, UCPs mediated helper effect on CTLs in other models of vaccinations
View article: Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
Supplementary Figure 5 from Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor Open
PDF file - 26K, UCP2 specific CD4 T cells recognize the mTERT-derived counterpart peptide p568
View article: La simulation temps réel au service de l’exploitation des liaisons à courant continu
La simulation temps réel au service de l’exploitation des liaisons à courant continu Open
110 REE N°1/2017 LE DEVELOPPEMENT DES LIAISONS A COURANT-CONTINU (HVDC) DOSSIER 2 Introduction Dans le cadre de l’insertion d’equi- pements a base d’electronique de puis- sance dans le reseau de transport, RTE a decide de se doter d’outils…